slotkoers
Shenzhen S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
70,15
CNY
|
+2,56%
|
|
+8,46%
|
-10,29%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
54.455
|
34.652
|
39.416
|
61.443
|
55.118
|
-
|
-
|
Bedrijfswaarde
1 |
54.455
|
34.652
|
38.934
|
60.397
|
52.840
|
51.665
|
52.987
|
K/w-verhouding
|
55,5
x
|
35,6
x
|
29,7
x
|
37,2
x
|
26,8
x
|
21,1
x
|
17,1
x
|
Dividendrendement
|
-
|
1,36%
|
1,4%
|
1,28%
|
1,78%
|
2,23%
|
2,59%
|
Marktkapitalisatie/omzet
|
24,8
x
|
13,6
x
|
12,9
x
|
15,6
x
|
11,2
x
|
8,86
x
|
7,27
x
|
Bedrijfswaarde/omzet
|
24,8
x
|
13,6
x
|
12,8
x
|
15,4
x
|
10,8
x
|
8,3
x
|
6,99
x
|
Bedrijfswaarde/EBITDA
|
45,8
x
|
27,8
x
|
26,3
x
|
31,3
x
|
21,2
x
|
16,6
x
|
14,1
x
|
Bedrijfswaarde/FCF
|
-
|
-
|
69,5
x
|
55,1
x
|
32,4
x
|
26,4
x
|
21,1
x
|
FCF Yield
|
-
|
-
|
1,44%
|
1,81%
|
3,08%
|
3,79%
|
4,73%
|
Price to Book
|
11,3
x
|
6,17
x
|
6,16
x
|
8,14
x
|
6,06
x
|
4,95
x
|
3,96
x
|
Aantal aandelen (in duizenden)
|
783.465
|
786.659
|
786.126
|
785.719
|
785.719
|
-
|
-
|
Referentieprijs
2 |
69,51
|
44,05
|
50,14
|
78,20
|
70,15
|
70,15
|
70,15
|
Datum van publicatie
|
30/03/21
|
21/04/22
|
6/04/23
|
11/04/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
2.195
|
2.545
|
3.047
|
3.930
|
4.914
|
6.223
|
7.578
|
EBITDA
1 |
1.190
|
1.248
|
1.479
|
1.928
|
2.490
|
3.109
|
3.752
|
Bedrijfsresultaat (EBIT)
1 |
1.099
|
1.137
|
1.504
|
1.895
|
2.335
|
2.981
|
3.670
|
Operationele Marge
|
50,05%
|
44,69%
|
49,35%
|
48,23%
|
47,52%
|
47,91%
|
48,43%
|
Resultaat voor belastingen (EBT)
1 |
1.097
|
1.136
|
1.501
|
1.893
|
2.361
|
3.004
|
3.688
|
Nettowinst (verlies)
1 |
939,1
|
973,7
|
1.328
|
1.654
|
2.059
|
2.616
|
3.216
|
Nettomarge
|
42,79%
|
38,25%
|
43,58%
|
42,08%
|
41,9%
|
42,04%
|
42,44%
|
WPA
2 |
1,252
|
1,239
|
1,689
|
2,104
|
2,621
|
3,329
|
4,093
|
Free Cash Flow
1 |
-
|
-
|
559,8
|
1.096
|
1.630
|
1.957
|
2.508
|
FCF-marge
|
-
|
-
|
18,37%
|
27,9%
|
33,17%
|
31,45%
|
33,1%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
37,85%
|
56,86%
|
65,46%
|
62,94%
|
66,84%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
42,16%
|
66,29%
|
79,16%
|
74,81%
|
77,99%
|
Dividend per aandeel
2 |
-
|
0,6000
|
0,7000
|
1,000
|
1,247
|
1,564
|
1,816
|
Datum van publicatie
|
30/03/21
|
21/04/22
|
6/04/23
|
11/04/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
---|
Omzet
1 |
-
|
989,3
|
1.865
|
-
|
1.022
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
459,8
|
865,5
|
501,4
|
528,5
|
Operationele Marge
|
-
|
46,48%
|
46,4%
|
-
|
51,73%
|
Resultaat voor belastingen (EBT)
1 |
-
|
458,8
|
864,3
|
501,3
|
527,5
|
Nettowinst (verlies)
|
355,1
|
394,9
|
750
|
-
|
-
|
Nettomarge
|
-
|
39,92%
|
40,21%
|
-
|
-
|
WPA
|
0,4517
|
0,5025
|
0,9542
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
27/04/23
|
24/08/23
|
24/08/23
|
26/10/23
|
11/04/24
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
-
|
-
|
482
|
1.047
|
2.278
|
3.453
|
2.131
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
560
|
1.096
|
1.630
|
1.957
|
2.508
|
ROE (netto-inkomsten/eigen vermogen)
|
22,4%
|
18,9%
|
21,9%
|
23,7%
|
23,1%
|
24,2%
|
23,6%
|
ROA (netto-inkomsten/totale activa)
|
21,4%
|
17%
|
18,9%
|
-
|
21,3%
|
22,4%
|
21,1%
|
Totale activa
1 |
4.382
|
5.721
|
7.015
|
-
|
9.679
|
11.691
|
15.241
|
Nettoactief per aandeel
2 |
6,130
|
7,130
|
8,140
|
9,600
|
11,60
|
14,20
|
17,70
|
Cashflow per aandeel
2 |
1,250
|
0,9800
|
1,220
|
1,810
|
2,630
|
3,140
|
3,670
|
Capex
1 |
253
|
343
|
403
|
322
|
359
|
449
|
657
|
Capex/omzet
|
11,53%
|
13,46%
|
13,21%
|
8,2%
|
7,31%
|
7,21%
|
8,67%
|
Datum van publicatie
|
30/03/21
|
21/04/22
|
6/04/23
|
11/04/24
|
-
|
-
|
-
|
Laatste slotkoers
70,15
CNY Gemiddelde koersdoel
80,56
CNY Spread / Gemiddelde doel +14,84% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -10,29% | 7,61 mld. | | +0,89% | 12,8 mld. | | +1,78% | 5,41 mld. | | -1,16% | 4,51 mld. | | +5,74% | 4,49 mld. | | -50,70% | 3,29 mld. | | +12,21% | 2,73 mld. | | -16,13% | 2,02 mld. | | -11,50% | 1,73 mld. | | -5,02% | 1,64 mld. |
Diagnostische en teststoffen
|